BETH STEINMETZ: Open Payments
NPI 1730675216 · ONTARIO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$832 in 51 payments from 10 companies in 2025. Trend: 2023 $135 · 2024 $263 · 2025 $832
Food & beverage: $832
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $595 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Lundbeck LLC | 1 | $19 |
| Krystal Biotech Inc | 1 | $17 |
| Amgen Inc. | 1 | $14 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: VRAYLAR, UBRELVY, LINZESS, QULIPTA, LEQVIO, CAPLYTA, NURTEC ODT, SHINGRIX.
Industry payments across OH — which companies pay providers there.
